Expert Report on latest data in the management of metastatic prostate cancer from ASCO 2022

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancerПодробнее

ESOU Online: EAU22 highlights in prostate cancerПодробнее

Expert Report on novel data in (neo)adjuvant treatment of melanoma from ASCO 2022Подробнее

ESMO Expert Report on antibody drug conjugates in the management of urothelial cancer @ASCO GU 2022Подробнее

ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022Подробнее

Expert Video Report on castration sensitive and resistant prostate cancer - 2021 ASCO Annual MeetingПодробнее

Expert Report on novelties in the management of gynaecological malignancies from ASCO 2022Подробнее

Critical Updates in Kidney, Prostate, and Bladder Cancer from ASCO 2023 with Dr. Toni ChoueiriПодробнее

Update on metastatic prostate cancer managementПодробнее

Targeting Advanced Prostate Cancer with PARP inhibitors: Who, When and How?Подробнее

ESMO 2020 Expert Video Report on precision medicine in prostate cancerПодробнее

Quality of life in treatment of metastatic prostate cancer patientsПодробнее

My First Symptoms of STAGE 4 Prostate Cancer!Подробнее

ASCO 2023 Expert Report on novelties in the treatment of colorectal cancer by S. StintzingПодробнее

GU ASCO Symposium 2022 SummaryПодробнее

#Brachytherapy For #ProstateCancer: Clinical Trials Results | #MarkScholzMD #PCRIПодробнее

Prostate Cancer Conference Highlights from ASCO 2022Подробнее

Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancerПодробнее

Treatment Updates for Advanced Prostate Cancer – 2023 ZERO Prostate Cancer SummitПодробнее